DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival

BACKGROUND: Locally advanced breast cancer is a heterogeneous disease with respect to response to neoadjuvant chemotherapy (NACT) and survival. It is currently not possible to accurately predict who will benefit from the specific types of NACT. DNA methylation is an epigenetic mechanism known to pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen, Christine Aaserød, Cao, Maria Dung, Fleischer, Thomas, Rye, Morten B., Knappskog, Stian, Eikesdal, Hans Petter, Lønning, Per Eystein, Tost, Jörg, Kristensen, Vessela N., Tessem, May-Britt, Giskeødegård, Guro F., Bathen, Tone F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233373/
https://www.ncbi.nlm.nih.gov/pubmed/35751095
http://dx.doi.org/10.1186/s13058-022-01537-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233373/
https://www.ncbi.nlm.nih.gov/pubmed/35751095
http://dx.doi.org/10.1186/s13058-022-01537-9

Ejemplares similares